On August 30, 2020, the Korea Economic Daily reported on Lee & Ko’s Healthcare Team, which is responding to the bio·healthcare market that has been on the sudden rise recently.

The Korea Economic Daily stated, “Companies’ demand for legal services has recently been increasing as new issues emerge every day which relate to bio-health technology development, such as SK Biopharm’s IPO, Kolon Life Science’s “Invossa” controversy, and clinical tests for coronavirus vaccine development.” The article further added that “Lee & Ko has also strengthened its team with professionals from medical and pharmaceutical backgrounds. Attorney Keum Nang Park, a licensed pharmacist who graduated from Seoul National University College of Pharmacy, leads a team of lawyers, many of whom are licensed physicians, pharmacists, or nurses, that make up the bio-pharmaceutical healthcare team.”